These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2184514)

  • 1. Prophylaxis of oropharyngeal candidiasis with fluconazole.
    Samonis G; Rolston K; Karl C; Miller P; Bodey GP
    Rev Infect Dis; 1990; 12 Suppl 3():S369-73. PubMed ID: 2184514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of candidiasis in cancer patients.
    Bodey GP; Samonis G; Rolston K
    Semin Oncol; 1990 Jun; 17(3 Suppl 6):24-8. PubMed ID: 2191444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
    Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
    Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
    Stevens DA; Greene SI; Lang OS
    Arch Intern Med; 1991 Dec; 151(12):2458-64. PubMed ID: 1747004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
    Corvò R; Amichetti M; Ascarelli A; Arcangeli G; Buffoli A; Cellini N; Cionini L; De Renzis C; Emiliani E; Franchini P; Gabriele P; Gobitti C; Grillo Ruggieri F; Bertoni F; Magrini SM; Marmiroli L; Orsatti M; Panizza GM; Tordiglione M; Ziccarelli L; Gava A; Zorat PL; Ghelfi R; Serra GF; Vitale V
    Eur J Cancer Care (Engl); 2008 May; 17(3):270-7. PubMed ID: 18419630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.
    Meunier F; Aoun M; Gerard M
    Rev Infect Dis; 1990; 12 Suppl 3():S364-8. PubMed ID: 2184513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
    Pagani JL; Chave JP; Casjka C; Glauser MP; Bille J
    J Antimicrob Chemother; 2002 Aug; 50(2):231-40. PubMed ID: 12161404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.
    Meunier F; Paesmans M; Autier P
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):196-9. PubMed ID: 7920166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of oropharyngeal candidiasis with clotrimazole.
    Yeo E; Alvarado T; Fainstein V; Bodey GP
    J Clin Oncol; 1985 Dec; 3(12):1668-71. PubMed ID: 4067613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
    Winston DJ; Chandrasekar PH; Lazarus HM; Goodman JL; Silber JL; Horowitz H; Shadduck RK; Rosenfeld CS; Ho WG; Islam MZ; Buell DN
    Ann Intern Med; 1993 Apr; 118(7):495-503. PubMed ID: 8442620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study.
    Marriott DJ; Jones PD; Hoy JF; Speed BR; Harkness JL
    Med J Aust; 1993 Mar; 158(5):312-6. PubMed ID: 8097273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
    Lim SG; Lee CA; Hales M; O'Doherty M; Winter M; Kernoff PB
    Aliment Pharmacol Ther; 1991 Apr; 5(2):199-205. PubMed ID: 1888820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
    Leen CL; Dunbar EM; Ellis ME; Mandal BK
    J Infect; 1990 Jul; 21(1):55-60. PubMed ID: 2200826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
    Eggimann P; Francioli P; Bille J; Schneider R; Wu MM; Chapuis G; Chiolero R; Pannatier A; Schilling J; Geroulanos S; Glauser MP; Calandra T
    Crit Care Med; 1999 Jun; 27(6):1066-72. PubMed ID: 10397206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
    Koc M; Aktas E
    Jpn J Clin Oncol; 2003 Feb; 33(2):57-60. PubMed ID: 12629054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole treatment of fungal infections in the immunocompromised host.
    Meunier F
    Semin Oncol; 1990 Jun; 17(3 Suppl 6):19-23. PubMed ID: 2191443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
    Flynn PM; Cunningham CK; Kerkering T; San Jorge AR; Peters VB; Pitel PA; Harris J; Gilbert G; Castagnaro L; Robinson P
    J Pediatr; 1995 Aug; 127(2):322-8. PubMed ID: 7636666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.